Back to Journals » Breast Cancer: Targets and Therapy » Volume 5

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer

Total article views   HTML views PDF downloads Totals
11,484 Dovepress* 10,794+ 1,839 12,633
PubMed Central* 690 232 922
Totals 11,484 2,071 13,555
*Since 17 June 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 0 3

View citations on PubMed Central and Google Scholar